Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Mastocytosis, Systemic 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1

Interventions

midostaurin 3avapritinib 2sarilumab 1obatoclax 1ibrutinib 1denileukin diftitox 1Imatinib Mesylate 1Everolimus 1Dasatinib 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mastocytosis, Systemic × obatoclax × Clear all
NCT00918931 2011-11-04

Obatoclax for Systemic Mastocytosis

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 2 charts
MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡